Affiliation:
1. Beijing Institute of Technology, Beijing 100081, China
Abstract
By using the “one-bead-one-component” strategy, we screened a targeting peptide for CD133, which was further engineered into glycopeptide micelles. The micelles can carry DOX and penetrate the BBB to achieve targeted killing of glioma cells.
Funder
National Natural Science Foundation of China
Natural Science Foundation of Beijing Municipality
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science,Biomedical Engineering,General Chemistry,General Medicine